Contents

Current Pharmaceutical Biotechnology, Volume 1 - Number 1

Preface

, 1(1): i

Alain Rolland


DOI: 10.2174/1389201003378988




Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

, 1(1): 1 - 9

A. J. Grillo-Lopez, C. A. White, B. K. Dallaire, C. L. Varns, C. D. Shen, A. Wei, J. E. Leonard, A. McClure, R. Weaver, S. Cairelli and J. Rosenberg


DOI: 10.2174/1389201003379059




Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug

, 1(1): 11 - 31

W. Jelkmann


DOI: 10.2174/1389201003379068




Growth Velocity, Final Height and Bone Mineral Metabolism of Short Children Treated Long Term with Growth Hormone

, 1(1): 33 - 46

Roberto Lanes


DOI: 10.2174/1389201003378997




Advances in Biotechnology for Tissue Engineering of Bone

, 1(1): 47 - 55

U. Ripamonti and J. R. Tasker


DOI: 10.2174/1389201003379031




Transcription Factors as Potential Targets for Therapeutic Drugs

, 1(1): 57 - 61

David S. Latchman


DOI: 10.2174/1389201003379022




Health Care Discovery, Novo Nordisk A/S, DK-2880 Bagsværd, Denmark

, 1(1): 63 - 71

Esper Boel, Tatjana Albrektsen, Jan Fleckner and John Selmer


DOI: 10.2174/1389201003379004




The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis

, 1(1): 73 - 82

Domenico Ribatti, Angelo Vacca, Luisa Roncali and Franco Dammacco


DOI: 10.2174/1389201003379040




Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals

, 1(1): 83 - 106

A. Zlobin, M. Jang and L. Miele


DOI: 10.2174/1389201003379013




Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases

, 1(1): 107 - 116

Ignacio Perez-Roger, Carmen Ivorra, Antonio Diez, Maria Jose Cortes, Enric Poch, Silvia M. Sanz-Gonzalez and Vicente Andres


DOI: 10.2174/1389201010001010107




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science